Potential impact of osteoporosis treatment on hip fracture trends.
Melton
L Joseph
LJ
Kanis
John A
JA
Johnell
Olof
O
D000368:Aged; D015519:Bone Density / Q000187:drug effects*; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism*; D002170:Canada; D002986:Clinical Trials as Topic; D012968:Etidronic Acid / Q000627:therapeutic use; D005260:Female; D006620:Hip Fractures / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy* / Q000453:epidemiology; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy; D010384:Pelvic Bones / Q000737:chemistry; D012306:Risk
D012968:Etidronic Acid